(MENAFN- EIN Presswire)
Autoinjectors Market5
The global autoinjectors market is expected to reach $5,732.6 million by 2027, registering a CAGR of 18.1% from 2020 to 2027, in terms of value.
WILMINGTON, DE, UNITED STATES, September 7, 2024 /EINPresswire / -- Autoinjectors Market - Global Outlook and Forecast 2023-2033 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2023-2033). The market Study is segmented by key a region that is accelerating the marketization. The report provides information on market research and development, growth drivers, and the changing investment structure of the Global Autoinjectors Market. Some of the key players profiled in the study are Abbott Laboratories, DiaSorin S.p.A., General Electric Company, Invitae Corporation, Johnson & Johnson, Leadient BioSciences Inc., Mallinckrodt plc, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceuticals Ltd. The global autoinjectors market is expected to reach $5,732.6 million by 2027, registering a CAGR of 18.1% from 2020 to 2027, in terms of value.
Click To Get Sample Copy:
Autoinjectors Market Key Growth Drivers:
Rising Prevalence of Chronic Diseases: Conditions such as diabetes, rheumatoid arthritis, multiple sclerosis, and severe allergies are on the rise, driving the demand for self-administration of drugs through autoinjectors. These devices provide patients with a convenient, effective way to manage long-term conditions at home.
Increasing adoption of biologics: Biologics, often used to treat autoimmune diseases and other chronic conditions, are commonly administered via autoinjectors. As biologics become more popular, the need for autoinjectors has increased.
Growing Preference for Self-Administration: Patients are becoming more interested in devices that allow for at-home drug administration, reducing the need for frequent doctor visits. This convenience enhances patient compliance and reduces healthcare costs.
Technological Advancements: Innovations in autoinjector design, such as improved safety features (e.g., needle retraction), customizable dosing, and user-friendly devices, are driving their adoption.
Aging Population: The growing elderly population, which is more prone to chronic diseases, further drives the demand for easy-to-use drug delivery systems like autoinjectors.
Rising Incidences of Anaphylaxis: The increasing number of allergies and the risk of life-threatening reactions have led to a higher demand for emergency autoinjectors, particularly for epinephrine.
Have Any Query? Ask Our Expert @:
The segments and sub-section of Autoinjectors market is shown below:
By Modality: Diagnostics and Treatment
By Application: Drug Delivery, Diagnostic Imaging, Vaccines, Regenerative Medicine, Implants, and Others
By Indication: Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Neurology, Urology, Ophthalmology, Immunology And Others
Some of the key players involved in the Market are: Abbott Laboratories, DiaSorin, General Electric Company, Invitae Corporation, Johnson & Johnson, Leadient BioSciences, Mallinckrodt, Merck & Co., Pfizer, Teva Pharmaceuticals.
Important years considered in the Autoinjectors study:
Historical year – 2017-2022; Base year – 2023; Forecast period** – 2023 to 2033 [** unless otherwise stated]
If opting for the Global version of Autoinjectors Market; then below country analysis would be included:
– North America (USA, Canada and Mexico)
– Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland and Rest of Europe)
– Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia and Rest of APAC)
– South America (Brazil, Argentina, Chile, Colombia, Rest of countries etc.)
– Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)
Key Findings Of The Study
. By type, the disposable autoinjectors segment accounted for a $1,021.7 in the global autoinjectors market in 2019.
. By application, the anaphylaxis segment account for the largest share and the rheumatoid arthritis segment is anticipated to grow with the highest CAGR of 18.7% throughout the forecast period.
. By end user, home care settings accounted for the largest share and expected to dominate the market with a CAGR of 18.3% during the forecast period.
. North America accounted for the largest share in the global autoinjectors market. Asia-Pacific is expected to witness highest growth rate for throughout the forecast period
Introduction about Autoinjectors Market
Autoinjectors Market Size (Sales) Market Share by Type (Product Category)
Autoinjectors Market by Application/End Users
Autoinjectors Sales (Volume) and Market Share Comparison by Applications
Global Autoinjectors Sales and Growth Rate (2023-2033)
Autoinjectors Competition by Players/Suppliers, Region, Type, and Application
Autoinjectors (Volume, Value, and Sales Price) table defined for each geographic region defined.
Autoinjectors Players/Suppliers Profiles and Sales Data
Key Raw Materials Analysis & Price Trends
Supply Chain, Sourcing Strategy and Downstream Buyers, Industrial Chain Analysis
........and view more in complete table of Contents
Procure Complete Report (220+ Pages PDF with Insights, Charts, Tables, and Figures) @
Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN06092024003118003196ID1108646157